Cefprozil (Cefzil)

08/01/1987 - "BMY-28100 was also more potent against infections of H. "
12/01/1992 - "[Clinical studies on cefprozil granules in pediatric skin soft tissues infections]."
06/01/1992 - "Clinical trials of cefprozil for treatment of skin and skin-structure infections: review."
03/01/1993 - "The low-rate of gastrointestinal and dermatologic side effects associated with cefprozil administration suggest that it may have a significant role in the management of patients with these infections. "
11/01/1992 - "Cefprozil (CFPZ, BMY-28100) granule preparation was studied for pharmacokinetic, bacteriological and clinical aspects in the pediatric infections. "

08/01/1993 - "Cefprozil can be considered a safe and reliable drug for the treatment of streptococcal pharyngitis in children."
10/01/1994 - "Four multicenter randomized clinical trials were conducted to compare the clinical efficacy and safety of cefprozil administered once or twice a day for the treatment of mild to moderate GABHS tonsillitis and pharyngitis. "
05/01/1993 - "The cefprozil concentrations in either the tonsillar or the adenoidal tissue at both dose levels over 3.17 h after dosing are much higher than the MICs for common pathogens which cause pharyngitis or tonsillitis."
06/01/1992 - "Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials."
06/01/1991 - "Cefprozil (500 mg once daily) was compared to cefaclor (250 mg three times daily) in an open, randomized, comparative trial for the treatment of acute group A beta-hemolytic streptococcal pharyngitis. "

10/01/1994 - "Four multicenter randomized clinical trials were conducted to compare the clinical efficacy and safety of cefprozil administered once or twice a day for the treatment of mild to moderate GABHS tonsillitis and pharyngitis. "
05/01/1993 - "The cefprozil concentrations in either the tonsillar or the adenoidal tissue at both dose levels over 3.17 h after dosing are much higher than the MICs for common pathogens which cause pharyngitis or tonsillitis."
06/01/1992 - "Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials."
11/01/2001 - "The bacteriologic eradication rate was significantly greater with cefprozil compared with erythromycin in children with pharyngitis/tonsillitis. "
02/01/1993 - "The clinical efficacy of cefprozil is similar to that of cefaclor in patients with tonsillitis or pharyngitis but the bacteriological efficacy of cefprozil is significantly greater than that of cefaclor. "

10/01/1991 - "Cefprozil, 500 mg once daily, appears to be an appropriate alternative for the treatment of acute, uncomplicated urinary tract infections."
11/01/1995 - "The results of this in vitro study indicate that oral administration of cefprozil might be efficacious in the treatment of community-acquired cutaneous, respiratory and urinary tract infections."
02/01/2004 - "After acute urinary tract infections (UTIs) were treated, the patients were divided into 3 groups randomly and TMP/SMZ was given to 21 patients, cephadroxil was given to 25 patients and cefprozil was given to 34 patients for 3 months--one dose at night. "
02/01/2004 - "Comparison of trimethoprim-sulfamethoxazole, cephadroxil and cefprozil as prophylaxis for recurrent urinary tract infections in children."
03/01/1992 - "Cefprozil is a new oral cephalosporin with an in vitro spectrum of activity that includes the pathogens most commonly associated with acute and uncomplicated urinary tract infections (UTIs). "

03/01/1992 - "The efficacy and safety of cefprozil at two dose levels were evaluated in 110 patients with acute uncomplicated bacterial sinusitis in an uncontrolled, noncomparative, Phase II trial. "
03/01/1992 - "A noncomparative study of cefprozil at two dose levels in the treatment of acute uncomplicated bacterial sinusitis."
03/01/1992 - "Evaluable patients had symptoms consistent with acute sinusitis, pathogens isolated at pretreatment susceptible to cefprozil, and a radiograph positive for sinusitis within 48 hours before treatment. "
01/01/1998 - "In summary, cefprozil 500mg twice daily is as well tolerated and as effective as cefuroxime axetil 250mg twice daily for the treatment of adolescent and adult patients with clinical signs and symptoms of acute sinusitis."
01/01/1998 - "Cefprozil versus Cefuroxime Axetil in the Treatment of Acute Sinusitis."